Analysis of Melanoma Educational Content and Skin of Color Representation on TikTok: Cross-Sectional Study. [PDF]
Jaguan D, Siddiqui Z, Choi JN.
europepmc +1 more source
Early Feasibility of Registration of Micro‐PET/CT Scans to Annotated 3D Specimen Models
ABSTRACT Background Intraoperative 18F‐fluorodeoxyglucose (18F‐FDG) micro‐positron emission tomography/computed tomography (micro‐PET/CT) is an emerging modality for margin assessment. Prior to clinical use, micro‐PET/CT margin distances must be correlated with gold‐standard histopathology.
Joaquin Austerlitz +13 more
wiley +1 more source
Adalimumab biosimilar uptake among dermatologists in Medicare Part D through 2023: A retrospective analysis using the Prescribers - by Provider and Drug dataset. [PDF]
Schedler NC +3 more
europepmc +1 more source
ABSTRACT Background Peronea arteria magna (PAM) is an established contraindication for fibula free flap due to concern for vascular compromise of the lower leg. Methods This is a case of a 74‐year‐old male with a history of multiply recurrent oral cavity cancer who had undergone prior free flap reconstruction who presented with a new oral cavity ...
Jacob Beiriger +7 more
wiley +1 more source
TCA-croton oil peels: unpredictable behavior and risk of severe hypertrophic scarring. [PDF]
Marçon CR, Soon SL, Wambier CG.
europepmc +1 more source
Superior Labial Artery Mucosal Flap (SLAM) for Reconstruction of Major Lower Lip Mucosal Defects
ABSTRACT Background The superior labial artery mucosal (SLAM) flap is a versatile, pedicled axial flap ideally suited for mucosal lining in lower lip reconstruction. Methods This article details the surgical anatomy and technique of the SLAM flap, highlighting its role as a standalone liner or mucosal adjunct to microvascular free tissue transfer in ...
Nicholas Shannon +2 more
wiley +1 more source
Redefining Treat-to-target in Atopic Dermatitis: Towards Meaningful, Patient-centred Disease Control - An ISAD Position Paper. [PDF]
Su J +29 more
europepmc +1 more source
Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy
ABSTRACT Background To evaluate botulinum toxin type A (BoNT‐A) for First Bite Syndrome (FBS) and assess a symptom‐guided “Follow‐the‐Pain” (FTP) injection strategy in patients with incomplete response to standard treatment. Methods Consecutive patients with postoperative FBS were treated with ultrasound‐guided intraparotid BoNT‐A injection.
Rosario Marchese‐Ragona +5 more
wiley +1 more source
Early outcomes of the Consolidated Appropriations Act: Missed opportunities for rural dermatology workforce growth. [PDF]
Lu K, Lipner SR.
europepmc +1 more source

